Oracle’s Record $638 Billion Backlog Is Overshadowed by a $300 Billion Concentration and a $40 Billion Capital Squeeze

Oracle's cloud revenue doubled and backlog hit $638B, but heavy reliance on OpenAI and a $40B capital plan spark investor concerns, sending shares down 14%.

Oracle’s latest quarterly results were a study in contrasts: revenue surged 21% to $19.2 billion, its cloud infrastructure business more than doubled year-over-year, and the backlog of contracted orders hit a staggering $638 billion. Yet the stock shed 14% in a single week, closing at €159.18 on Friday. The culprit is not operational performance but a pair of structural risks—an extreme reliance on a single customer and a $40 billion capital programme that threatens to dilute shareholders just as the company cranks up its spending.

Nearly half of that $638 billion backlog is tied to one client: OpenAI, which accounts for roughly $300 billion in committed revenue. While the relationship underscores Oracle’s role in powering the AI boom, it also creates a dangerous single-point vulnerability. A shift in OpenAI’s strategy—or its cloud provider mix—could wipe out a massive chunk of future revenue. The market is now pricing in that asymmetry, a risk that becomes harder to ignore as the order book becomes more concentrated.

Beyond the backlog, Oracle delivered strong operational metrics. Total revenue climbed to $19.2 billion, propelled by a 93% jump in cloud infrastructure revenue and a 404% surge in its multicloud AI database business—the fastest-growing segment in the company’s history. The company also announced a quarterly dividend of $0.50 per share, payable at the end of July. But these headline numbers have done little to ease investor unease.

The cost of building out that infrastructure is staggering. Capital expenditures for fiscal 2026 reached $55.7 billion, up 162% from the prior year and well above Oracle’s own guidance. Free cash flow swung to a negative $23.7 billion as the company invested aggressively in data centres and GPU capacity. CFO Hilary Maxson has guided for roughly $70 billion in capex in fiscal 2027, an increase that further strains the balance sheet.

To fund this spending, Oracle raised $48 billion last fiscal year—$43 billion in debt and $5 billion in equity. For the current year, management has lined up an additional $40 billion, half of which is expected to come from equity sales. That $20 billion equity programme will be executed directly in the open market, raising the spectre of significant dilution. The mechanics are self-reinforcing: as the stock falls, Oracle must sell more shares to raise the same amount, creating a downward spiral that keeps pressure on the share price.

Technically, the shares are clinging to support. The stock is trading just below its 50-day moving average of €158.89 and about 10% below the 200-day line. It is more than 43% off the 52-week high of €280.70. The relative strength index sits at 42.4, indicating a moderately oversold condition but no panic. Analyst consensus points to a median price target of €220.45, implying roughly 40% upside, but the wide gap between target and current price reflects deep uncertainty about the path to profitability.

For the first quarter of fiscal 2027, Oracle guided for revenue growth of up to 29%. Investors were hoping for a more aggressive target, especially given the backlog. The real test will come on September 10, when Oracle reports Q1 results. Until then, the equity programme will continue to weigh on any recovery attempt. The key question remains whether the company can convert its massive order book into cash-generating revenue at margins that satisfy the market.

Oracle’s long-term AI thesis rests on its ability to deliver the infrastructure that hyperscalers and AI labs need. The record backlog proves demand is real. But the cost of meeting that demand is creating a financial strain that investors are not willing to overlook—at least not until the cash flow turns positive and the dilution risk recedes.